1-3 of 3
Chen Zhengming
Close
Sort by
Journal Articles

Development of a Conditional Event-Free Survival Tool in Diffuse Large B-Cell Lymphoma

Danny Luan, Chen Zhengming, Lasse Hjort Jakobsen, Matthew J. Maurer, Tarec Christoffer Christoffer El-Galaly, Loretta J. Nastoupil, James R. Cerhan, Christopher R. Flowers, Brian K. Link, Izidore S. Lossos, Deborah M. Stephens, Thomas M. Habermann, Grzegorz S. Nowakowski, Nancy L. Bartlett, Jonathan W. Friedberg, Brad S. Kahl, John P. Leonard, Peter De Nully Brown, Karin E. Smedby, Mats Jerkeman, Peter Martin
Journal: Blood
Blood (2022) 140 (Supplement 1): 1921–1923.
https://doi.org/10.1182/blood-2022-164692
Published: 2022
Journal Articles

BTG1 Mutation Promotes Aggressive Lymphoma Development By Lowering the Threshold to MYC Activation and Generating "Super-Competitor" B Cells

Coraline Mlynarczyk, Matthew Teater, Juhee Pae, Theinmozhi Arulraj, Christopher R Chin, Ling Wang, Jonatan Ersching, Ekaterina Kots, Amy Chadburn, Ersilia Barin, Hui Xian Poh, Hannah M Isles, Chen Zhengming, Hao Shen, Arnab Bandyopadhyay, Kenneth B Hoehn, Diu T.T. Nguyen, Ashley S Doane, Huimin Geng, Muhammad H Rehman, Jonah Melnick, Wyatt Morgan, Olivier Elemento, Michael G Kharas, David W. Scott, Samie R Jaffrey, Michael Meyer-Hermann, George Khelashvili, Gabriel Victora, Ari Melnick
Journal: Blood
Blood (2021) 138 (Supplement 1): 359.
https://doi.org/10.1182/blood-2021-149921
Published: 2021
Journal Articles

Understanding the Differences between Clinical Trial Participants and Real-World Patients with Non-Hodgkin Lymphoma

Tolulope Fatola, Sarah C. Rutherford, John N. Allan, MD, Jia Ruan, MD PhD, Richard R. Furman, MD, Chen Zhengming, PhD MPH, MS, Arcania Garcia, Channy Kong, Erica B Bhavsar, BS, Joshua Falsenfeld, John P. Leonard, MD, Peter Martin, FRCPC, MD MS
Journal: Blood
Blood (2018) 132 (Supplement 1): 2970.
https://doi.org/10.1182/blood-2018-99-113872
Published: 2018